Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 31722-665

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 31722-665). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20mgcontainerlabelofeso (20mgcontainerlabelofeso)

Label for Esomeprazole Magnesium delayed-release capsules, USP 20 mg, containing 30 capsules. The label includes the NDC 31722-664-30 and states it is for prescription use only. Manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ, and made by Hetero Labs Limited, India. It provides storage instructions and a U.S. contact number for medication guides.*

FDA Label Image

40mgcontainerlabelofeso (40mgcontainerlabelofeso)

Label for Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg, containing 30 capsules. The label features the Camber Pharmaceuticals, Inc. logo and states that these prescription capsules are manufactured for Camber Pharmaceuticals and by Hetero Labs Limited in India. The label includes storage instructions, a pharmacist dispensing note, a barcode, and contact information for the U.S.*

FDA Label Image

Esomeprazolemagnesiumfigure1 (Esomeprazolemagnesiumfigure1)

Chemical structure diagram of Esomeprazole Magnesium, showing the molecular components including magnesium ion complex and associated chemical bonds.*

FDA Label Image

Esmoprazolemagnesiumfigure2 (Esomeprazolemagnesiumfigure2)

A line graph showing the percentage maintained over a 6-month period for Esomeprazole Magnesium delayed-release capsules at 40 mg, 20 mg, and 10 mg doses compared to placebo. The y-axis represents percent maintained, and the x-axis represents months, with multiple lines depicting the different doses and placebo group trends over time.*

FDA Label Image

Esmoprazolemagnesiumfigure3 (Esomeprazolemagnesiumfigure3)

A line graph showing the percent maintained over a 6-month period for Esomeprazole Magnesium delayed-release capsules at 10 mg, 20 mg, and 40 mg doses compared to placebo. The y-axis represents percent maintained, and the x-axis represents months, with multiple data points and trend lines for each treatment group.*

FDA Label Image

Esomeprazolemagnesiumfigure4 (Esomeprazolemagnesiumfigure4)

A line graph depicting the percentage of patients symptom-free over 28 days. The graph compares Esomeprazole Magnesium Delayed-Release Capsules at 40 mg and 20 mg doses to a placebo, with the vertical axis showing the percent symptom-free and the horizontal axis representing diary days.*

FDA Label Image

Esomeprazolemagnesiumfigure5 (Esomeprazolemagnesiumfigure5)

A line graph comparing the percentage of patients symptom-free over 28 days among three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, Esomeprazole Magnesium Delayed-Release Capsules 20 mg, and placebo. The x-axis represents diary days from 0 to 28, and the y-axis represents the percent of patients symptom-free, ranging from 0 to 100.*

FDA Label Image

Camber (Camber)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.